Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog

Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog

Why Invest in an HIV Gene Therapy Cure

Why Invest in an HIV Gene Therapy Cure?

Dec 27, 2018

Research and innovation to cure HIV is developing fast. American Gene Technologies® (AGT™)  is emerging as a leader in the field with their first functional cure for HIV, expected to enter clinical trials in 2019. Unlike the current antiretrovirals used in HIV treatment, AGT’s solution is…

Read More
The Next Generation of Gene Therapy Companies

The Next Generation of Gene Therapy Companies

Dec 18, 2018

The future of medicine is bright. This year brought several first in class technologies over the finish line. The underpinning of these radical medical developments is the understanding of how human genes can be modified to cure diseases and save lives. The technology which captured…

Read More
The Gene Therapy Market is going to produce a Microsoft

The Gene Therapy Market is going to produce a Microsoft

Nov 30, 2018

The most common analogy used to compare the science of DNA to other industries is that of computer software. DNA can be viewed as a series of commands (genes) that are coded in four nucleotides (represented by A, G, C, and T). Those letters are…

Read More
AGT CEO Jeff Galvin speaks about the tremendous potential and progress in gene and cell therapy at TEDx Georgetown

HOW CREATIVITY CURES, JEFF GALVIN, AGT CEO, TEDxGEORGETOWN

Apr 17, 2018

Subscribe to our YouTube Channel CEO Jeff Galvin tours nationally to evangelize AGT’s mission and raise awareness of AGT’s commitment to pursuing solutions for patients suffering from intractable diseases. Watch his latest TEDx talk to learn about the tremendous potential and progress in gene and…

Read More
AGT Announces First-Ever Reddit AMA on the Potential of Gene Therapies

AGT Announces First-Ever Reddit AMA on the Potential of Gene Therapies

Apr 21, 2016

We are proud to have participated in our first-ever Reddit AMA on April 21, 2016. AGT CEO, Jeff Galvin and Chief Science Officer, Dr. David Pauza discussed the future of gene therapy and viral vectors as a delivery vehicle.   See the full Reddit AMA HERE…

Read More
CEO Jeff Galvin Addresses Congress on the Biotechnology Investment Tax Credit

CEO Jeff Galvin Addresses Congress on the Biotechnology Investment Tax Credit

Mar 8, 2016

Jeff Galvin, CEO of American Gene Technologies® provided testimony in a Senate Hearing on March 8, 2016 in support of Maryland’s Biotechnology Investment Incentive Tax Credit. His goal? To alter the definition of “qualified Maryland biotechnology company” so that an active business may claim the…

Read More

Subscribe to Receive our Blog Updates

Subscribe to our blog updates to be notified when we release new content!

Blog Categories

Follow AGT on Social Media

AGT on Facebook

Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. loom.ly/96TZ0jU#HIV #celltherapy #biotech ... See MoreSee Less
View on Facebook
M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest. ... See MoreSee Less
View on Facebook
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on the research and what lies ahead in our mission to find a cure for HIV! loom.ly/jAThqIU#HIV #hivcure #HIVresearch #clinicaltrials ... See MoreSee Less
View on Facebook
Can genetic evidence make drugs more effective? A new study in Nature suggests YES. Drug mechanisms with genetic support have a 2.6x higher chance of success. loom.ly/NxSxjXk#genetics #science #Healthcare ... See MoreSee Less
View on Facebook